Covaxin overall 77.8% effective, claims Bharat Biotech in final Phase 3 data, yet to be peer-reviewed

Bharat Biotech’s Covaxin is overall 77.8 per cent effective “against symptomatic COVID-19”, the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The…

Similar Articles

Comments

spot_img

Most Popular

You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign